Intelligence Platform
Patents
Browse 218 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9732110
Nucleoside and nucleotide derivatives
granted patentUS 9718851
Deuterated nucleoside/tide derivatives
granted patentUS 9675632
Nucleoside and nucleotide derivatives
granted patentUS 9676802
Hepatitis C virus inhibitors
granted patentUS 9669095
Cyclosporin analogues for preventing or treating hepatitis C infection
granted patentUS 9616099
Cyclosporin analogues for preventing or treating hepatitis C infection
granted patentUS 9603895
Cyclosporin analogues for preventing or treating hepatitis C infection
granted patentUS 9526769
Macrocylic oximyl hepatitis C protease inhibitors
granted patentUS 9309279
Macrocyclic hepatitis C serine protease inhibitors
granted patentUS 9220748
Macrocyclic proline derived HCV serine protease inhibitors
granted patentUS 9221878
Cyclosporin analogues for preventing or treating hepatitis C infection
granted patentUS 9193740
Bismacrocyclic compounds as hepatitis C virus inhibitors
granted patentUS 9156886
Cyclosporin analogues for preventing or treating hepatitis C infection
granted patentUS 9156818
Hepatitis C virus inhibitors
granted patentUS 9127021
Hepatitis C virus inhibitors
granted patentUS 9085599
2β²allene-substituted nucleoside derivatives
granted patentUS 9060971
Combination pharmaceutical agents as inhibitors of HCV replication
granted patentUS 9000020
Linked dibenzimidazole antivirals
granted patentUS 8962551
Quinoxalinyl derivatives
granted patentUS 8951964
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
granted patentUS 8951998
Quinoxaline-containing compounds as hepatitis C virus inhibitors
granted patentUS 8940688
Fluorinated tripeptide HCV serine protease inhibitors
granted patentUS 8936781
Macrocyclic compounds as hepatitis C virus inhibitors
granted patentUS 8933110
Hepatitis C virus inhibitors
granted